ACL Versus ALL + ACL Study

Launched by ASCOPHARM GROUPE NOVASCO · Nov 9, 2018

Keywords

ClinConnect Summary

The aim is to evaluate the rate of re-rupture and to analyze knee function through scores analysis as International Knee Documentation Committee Subjective Knee (IKDC), Knee injury and osteoarthritis outcome score (KOOS), Lysholm-Tegner, and by objective measurements of laximetry and rotation.

This study should include 2 groups of 296 patients with isolated ACL (antero crusader ligament) with clinical rotation :

* operated by a conventional patellar tendon technique (first group)
* operated by a technique combining a ALL (anterolateral ligament) and ACL plasty for the second group

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Patients with total isolated antero crusader ligament (ACL) rupture who are candidates for surgical reconstruction
• • Patients between 18 and 35 years old
• • Patients with weekly sporting activities
• • Patients with chronic rotatory instability with a positive pivot shift
• • Patients who have been informed and do not object the research
• Exclusion Criteria:
• • Patients with multi-ligament knee involvement
• • Patients under 18 years old or over 35 years old
• • Patients with a BMI of under 18.5 or over 30
• • Patients with any contraindication to general anaesthesia
• • Professional sportsmen/women
• • Patients with congenital malformation or a rheumatic disease
• • Patients with repeated antero crusader ligament (ACL) rupture
• • Patients with serious ligament disease in the contralateral knee
• • Patients who refuse to take part in the study